Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Neuroendocrine tumour of the lung
ADR ID BADD_A10510
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.19      Respiratory and mediastinal neoplasms malignant and unspecified
16.19.02      Respiratory tract and pleural neoplasms malignant cell type unspecified NEC
16.19.02.011      Neuroendocrine tumour of the lung
05      Endocrine disorders
05.08      Neoplastic and ectopic endocrinopathies
05.08.01      Endocrine neoplasms NEC
05.08.01.021      Neuroendocrine tumour of the lung
22      Respiratory, thoracic and mediastinal disorders
22.08      Respiratory tract neoplasms
22.08.01      Lower respiratory tract neoplasms
22.08.01.031      Neuroendocrine tumour of the lung
Description Not Available
MedDRA Code 10078174
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neuroendocrine tumour of the lung | Neuroendocrine tumor of the lung | Combined large cell neuroendocrine carcinoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01008Gefitinib0.000112%
BADD_D01668Pantoprazole0.000016%
BADD_D02053Sofosbuvir0.000282%
The 1th Page    1    Total 1 Pages